Belmont University’s Thomas F. Frist, Jr. College of Medicine has been told it will not move to the next level of accreditation for at least two years, a gut punch for a program that only opened in 2023 and is still operating under preliminary status. Students were informed Thursday that the Liaison Committee on Medical Education, or LCME, is holding the school at its current level after a recent review.
Belmont says day‑to‑day life for students is not supposed to change. Classroom instruction and clinical rotations are expected to continue, and the university says it will not raise tuition to cover the corrective work. Students who decide they have had enough are being offered refunds if they opt to withdraw and declare that intent by August 25, 2026.
According to Nashville Banner, the LCME decision followed a February campus visit by an evaluation team and means the program will not move forward on the typical accreditation timetable. The LCME directory still lists the Thomas F. Frist, Jr. College of Medicine as having preliminary accreditation and shows Meharry Medical College in Nashville as being on probation.
What Belmont Told Students
On its accreditation page, Belmont University says the medical school has a remediation plan in place and that its admissions cycle is continuing as normal. The university says students’ schedules, clinical placements and tuition rates will remain in place while the college works through LCME concerns…